Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2017 Filed Nov 22, 2017 21:50 UTC Amendment |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 2,000 | $216.06 | $432,113.60 |
DisclosureSEC source: 0001190251-17-000007 · edgardoc.xml · nonDerivative · entry 1 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.00 to $216.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 21:09 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001073397-17-000006 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,716 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 20:07 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,200 | $206.29 | $247,545.12 |
DisclosureSEC source: 0001073397-17-000005 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,716 F2 · price: he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.05 to $206.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 20:07 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 3,800 | $205.68 | $781,590.08 |
DisclosureSEC source: 0001073397-17-000005 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,916 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.05 to $206.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 72,026 | $58.79 Strike: $58.79 | $4,234,408.54 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,366 Underlying: Common Stock · 72,026 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 72,026 | $190.00 | $13,684,940.00 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 72,026 | $58.79 | $4,234,408.54 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,937 Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 25,769 | $58.79 Strike: $58.79 | $1,514,959.51 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,392 Underlying: Common Stock · 25,769 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 25,769 | $190.00 | $4,896,110.00 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 25,769 | $58.79 | $1,514,959.51 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,680 Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 5 | $58.79 Strike: $58.79 | $293.95 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,161 Underlying: Common Stock · 5 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 5 | $190.00 | $950.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 5 | $58.79 | $293.95 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,916 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $43.12 Strike: $43.12 | $64,680.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 18 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2021-02-02 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $39.38 Strike: $39.38 | $59,070.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 17 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2021-10-19 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $37.00 Strike: $37.00 | $55,500.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 16 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-07-21 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $36.60 Strike: $36.60 | $54,900.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 15 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-10-20 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $33.52 Strike: $33.52 | $50,280.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 14 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-04-21 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $32.40 Strike: $32.40 | $48,600.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · derivative · entry 13 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-02-03 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 200 | $190.85 | $38,170.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 12 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,091 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.70 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 4,600 | $189.49 | $871,640.20 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 11 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,291 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.20 to $190.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 1,200 | $189.00 | $226,800.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 10 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,891 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.20 to $189.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 300 | $190.67 | $57,200.01 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 9 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,091 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.40 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 2,100 | $189.48 | $397,913.04 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 8 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,391 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.25 to $190.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 600 | $189.01 | $113,408.10 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 7 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,491 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.25 to $189.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $39.38 | $59,070.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 6 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,091 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $36.60 | $54,900.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 5 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,591 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $43.12 | $64,680.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 4 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,091 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $37.00 | $55,500.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 3 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,591 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $33.52 | $50,280.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 2 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,091 Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 16:44 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $32.40 | $48,600.00 |
DisclosureSEC source: 0001190251-17-000004 · edgardoc.xml · nonDerivative · entry 1 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,591 Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,200 | $58.79 Strike: $58.79 | $129,338.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,166 Underlying: Common Stock · 2,200 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 2,000 | $191.00 | $382,000.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 200 | $190.00 | $38,000.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 2,200 | $58.79 | $129,338.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,111 Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 22:52 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 463 | $181.25 | $83,918.75 |
DisclosureSEC source: 0001073398-17-000012 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,330 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 07, 2017 Filed Sep 7, 2017 21:19 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 102 | $174.54 | $17,802.70 |
DisclosureSEC source: 0001669639-17-000006 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 07, 2017 Filed Sep 7, 2017 21:19 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 1,682 | $174.46 | $293,444.92 |
DisclosureSEC source: 0001669639-17-000006 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:20 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 100 | $175.10 | $17,510.00 |
DisclosureSEC source: 0001073398-17-000011 · edgardoc.xml · nonDerivative · entry 3 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,793 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:20 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 300 | $175.05 | $52,515.00 |
DisclosureSEC source: 0001073398-17-000011 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,893 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:20 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 3,000 | $175.00 | $525,000.00 |
DisclosureSEC source: 0001073398-17-000011 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,193 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| September 01, 2017 Filed Jan 2, 2018 16:43 UTC |
McGrody Kevin JController
|
GrantCommon Stock · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001615192-18-000001 · edgardoc.xml · derivative · entry 1 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,714 Underlying: Common Stock · 1,714 shares Expires 2020-09-01 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F2 · derivative.underlying_shares: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| August 31, 2017 Filed Aug 31, 2017 23:52 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 2,700 | $173.98 | $469,737.90 |
DisclosureSEC source: 0001073398-17-000010 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,193 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 31, 2017 Filed Aug 31, 2017 23:52 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 700 | $173.98 | $121,783.76 |
DisclosureSEC source: 0001073398-17-000010 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,893 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 3,049 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Underlying: Common Stock · 3,049 shares Expires 2018-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Tax withholdingCommon Stock | 1,265 | $167.95 | $212,456.75 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-17-000005 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2017 Filed Jul 20, 2017 22:12 UTC |
SWINNEY ROBERT SDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 8,500 | $35.00 Strike: $35.00 | $297,500.00 |
DisclosureSEC source: 0001073398-17-000007 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2017-08-14 Read SEC document |
| July 20, 2017 Filed Jul 20, 2017 22:12 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 4,477 | $175.00 | $783,475.00 |
DisclosureSEC source: 0001073398-17-000007 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,816 F1 · security: These securities are Restricted Stock Units. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 20, 2017 Filed Jul 20, 2017 22:12 UTC |
SWINNEY ROBERT SDirector
|
OtherCommon Stock | 8,500 | $35.00 | $297,500.00 |
DisclosureSEC source: 0001073398-17-000007 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,293 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.